• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4609572)   Today's Articles (11162)   Subscriber (49378)
For: Salwan A, Hagemeier NE, Tudiver F, Dowling-McClay K, Foster KN, Arnold J, Alamian A, Pack RP. Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis. J Am Pharm Assoc (2003) 2020;60:e173-e178. [PMID: 32669219 DOI: 10.1016/j.japh.2020.06.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Revised: 06/03/2020] [Accepted: 06/09/2020] [Indexed: 12/29/2022]
Number Cited by Other Article(s)
1
Salwan A, Mathis SM, Brooks B, Hagemeier NE, Tudiver F, Foster KN, Alamian A, Pack RP. A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee. Res Social Adm Pharm 2024:S1551-7411(24)00204-3. [PMID: 38981793 DOI: 10.1016/j.sapharm.2024.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 07/02/2024] [Accepted: 07/03/2024] [Indexed: 07/11/2024]
2
Light AE, Green TC, Freeman PR, Zadeh PS, Burns AL, Hill LG. Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists: Results From a National Sample. SUBSTANCE USE & ADDICTION JOURNAL 2024;45:211-221. [PMID: 38258805 DOI: 10.1177/29767342231215178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2024]
3
Jarrett JB, Bratberg J, Burns AL, Cochran G, DiPaula BA, Dopp AL, Elmes A, Green TC, Hill LG, Homsted F, Hsia SL, Matthews ML, Ghitza UE, Wu LT, Bart G. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy. Subst Abus 2023;44:264-276. [PMID: 37902032 PMCID: PMC10870734 DOI: 10.1177/08897077231203849] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2023]
4
Pasqualini I, Rullán PJ, Deren M, Krebs VE, Molloy RM, Nystrom LM, Piuzzi NS. Team Approach: Use of Opioids in Orthopaedic Practice. JBJS Rev 2023;11:01874474-202303000-00008. [PMID: 36972360 DOI: 10.2106/jbjs.rvw.22.00209] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]
5
Skaggs P, Bell SB, Scutchfield FD, Robinson LE. Providers' Stigmas and the Effects on Patients with Opioid Use Disorder: A Scoping Review. JOURNAL OF APPALACHIAN HEALTH 2023;4:87-102. [PMID: 38026051 PMCID: PMC10655729 DOI: 10.13023/jah.0403.06] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/01/2023]
6
Nichols MA, Kepley KL, Rosko KS, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Community pharmacist-provided opioid intervention frequencies and barriers. J Am Pharm Assoc (2003) 2023;63:336-342. [PMID: 36369075 PMCID: PMC9942609 DOI: 10.1016/j.japh.2022.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 09/30/2022] [Accepted: 10/04/2022] [Indexed: 11/05/2022]
7
Welsh JW, Yarbrough CR, Sitar SI, Mataczynski MJ, Peralta AM, Kan M, Crawford ND, Conrad TA, Kee C, Young HN. Demographic and socioeconomic correlates to buprenorphine access in pharmacies. J Am Pharm Assoc (2003) 2022;63:751-759. [PMID: 36658013 DOI: 10.1016/j.japh.2022.12.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Revised: 11/28/2022] [Accepted: 12/12/2022] [Indexed: 12/23/2022]
8
Pollini RA, Slocum S, Ozga JE, Joyce R, Xuan Z, Green TC, Walley AY. Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program. J Am Pharm Assoc (2003) 2022;62:1546-1554. [PMID: 35450833 PMCID: PMC9464657 DOI: 10.1016/j.japh.2022.03.015] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 03/10/2022] [Accepted: 03/16/2022] [Indexed: 11/29/2022]
9
Giravi HY, Biskupiak Z, Tyler LS, Bulaj G. Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care. Front Digit Health 2022;4:884047. [PMID: 35770137 PMCID: PMC9234128 DOI: 10.3389/fdgth.2022.884047] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Accepted: 05/16/2022] [Indexed: 11/17/2022]  Open
10
Freibott CE, Walker A, Maio V, Frasso R. Educational programs implemented for pharmacists after state passage of a standing order for naloxone: A systematic review of current practices. J Am Pharm Assoc (2003) 2021;61:e19-e27. [PMID: 33386240 DOI: 10.1016/j.japh.2020.11.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Revised: 10/30/2020] [Accepted: 11/18/2020] [Indexed: 11/24/2022]
11
Rao D, Giannetti V, Kamal KM, Covvey JR, Tomko JR. Pharmacist Views Regarding the Prescription Opioid Epidemic. Subst Use Misuse 2021;56:2096-2105. [PMID: 34429024 DOI: 10.1080/10826084.2021.1968434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA